These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12412822

  • 21. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M, Aschoff J, May A, Charlesworth BR, REALIZE Study Team.
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [Abstract] [Full Text] [Related]

  • 22. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older.
    McKeage K.
    Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634
    [Abstract] [Full Text] [Related]

  • 23. A comparison of the pharmacokinetics and tolerability of the novel antimigraine compound zolmitriptan in adolescents and adults.
    Dixon R, Engleman K, Kemp J, Ruckle JL.
    J Child Adolesc Psychopharmacol; 1999 Feb; 9(1):35-42. PubMed ID: 10357516
    [Abstract] [Full Text] [Related]

  • 24. Distribution of zolmitriptan into the CNS in healthy volunteers: a positron emission tomography study.
    Wall A, Kågedal M, Bergström M, Jacobsson E, Nilsson D, Antoni G, Frändberg P, Gustavsson SA, Långström B, Yates R.
    Drugs R D; 2005 Feb; 6(3):139-47. PubMed ID: 15869317
    [Abstract] [Full Text] [Related]

  • 25. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH, Hussey EK, Shaw S, Fuseau E, Duquesnoy C, Pakes GE.
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [Abstract] [Full Text] [Related]

  • 26. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
    Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, Bigal ME.
    Neurology; 2007 Aug 28; 69(9):821-6. PubMed ID: 17724283
    [Abstract] [Full Text] [Related]

  • 27. Intranasal zolmitriptan for the treatment of acute migraine.
    Tepper SJ, Chen S, Reidenbach F, Rapoport AM.
    Headache; 2013 Sep 28; 53 Suppl 2():62-71. PubMed ID: 24024604
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: a double-blind, placebo-controlled study.
    Smith DA, Cleary EW, Watkins S, Huffman CS, Dilzer SC, Lasseter KC.
    J Clin Pharmacol; 1998 Aug 28; 38(8):685-93. PubMed ID: 9725543
    [Abstract] [Full Text] [Related]

  • 29. Oral zolmitriptan is effective in the acute treatment of cluster headache.
    Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ.
    Neurology; 2000 May 09; 54(9):1832-9. PubMed ID: 10802793
    [Abstract] [Full Text] [Related]

  • 30. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J.
    Headache; 2006 Jan 09; 46(1):101-9. PubMed ID: 16412157
    [Abstract] [Full Text] [Related]

  • 31. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ, Charlesworth BR, Green J, Färkkilä M, Diener HC, Hansen SB, Gawel M, INDEX Study Group.
    Headache; 2005 Jan 09; 45(1):17-24. PubMed ID: 15663608
    [Abstract] [Full Text] [Related]

  • 32. The novel anti-migraine compound zolmitriptan (Zomig 311C90) has no clinically significant interactions with paracetamol or metoclopramide.
    Seaber EJ, Ridout G, Layton G, Posner J, Peck RW.
    Eur J Clin Pharmacol; 1997 Jan 09; 53(3-4):229-34. PubMed ID: 9476036
    [Abstract] [Full Text] [Related]

  • 33. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
    Vyas TK, Babbar AK, Sharma RK, Misra A.
    J Drug Target; 2005 Jun 09; 13(5):317-24. PubMed ID: 16199375
    [Abstract] [Full Text] [Related]

  • 34. Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90).
    Rolan P.
    Cephalalgia; 1997 Oct 09; 17 Suppl 18():21-7. PubMed ID: 9399014
    [Abstract] [Full Text] [Related]

  • 35. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.
    Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ.
    Arch Neurol; 2006 Nov 09; 63(11):1537-42. PubMed ID: 16966497
    [Abstract] [Full Text] [Related]

  • 36. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
    Spierings EL, Rapoport AM, Dodick DW, Charlesworth B.
    CNS Drugs; 2004 Nov 09; 18(15):1133-41. PubMed ID: 15581383
    [Abstract] [Full Text] [Related]

  • 37. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
    Dowson AJ, MacGregor EA, Purdy RA, Becker WJ, Green J, Levy SL.
    Cephalalgia; 2002 Mar 09; 22(2):101-6. PubMed ID: 11972576
    [Abstract] [Full Text] [Related]

  • 38. Effect of hepatic impairment on the pharmacokinetics of zolmitriptan.
    Dixon R, French S, Kemp J, Sellers M, Leclerc V, Delvaux M, Rautureau J.
    J Clin Pharmacol; 1998 Aug 09; 38(8):694-701. PubMed ID: 9725544
    [Abstract] [Full Text] [Related]

  • 39. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
    Hedlund C, Rapoport AM, Dodick DW, Goadsby PJ.
    Headache; 2009 Oct 09; 49(9):1315-23. PubMed ID: 19788472
    [Abstract] [Full Text] [Related]

  • 40. Intranasal absorption of rizatriptan--in vivo pharmacokinetics and bioavailability study in humans.
    Chen J, Jiang XG, Jiang WM, Gao XL, Mei N.
    Pharmazie; 2005 Jan 09; 60(1):39-41. PubMed ID: 15702515
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.